Chris Larsen, MD renal pathologist at arkana laboratories

Chris Larsen, MD Executive Director,
Nephropathologist

About

Dr. Chris Larsen joined Arkana in 2009 after graduating from medical school at the University of Arkansas for Medical Sciences, completing an anatomic pathology residency at Emory University, and completing a renal pathology fellowship at Arkana Laboratories. Dr. Larsen helped develop our molecular lab, directs our research activities, and serves as executive director of Arkana Laboratories. He is an avid researcher who has published extensively in the areas of membranous glomerulopathy, APOL1-related kidney disease, LECT2 amyloidosis, monoclonal gammopathy of renal significance and has described new and esoteric kidney diseases such as membranous-like glomerulopathy with masked IgG kappa deposits and LRP2-associated nephropathy. In his free time, Dr. Larsen enjoys spending time outdoors and with his wife and children.

Dr. Chris Larsen is a member of the College of American Pathologists, the United States and Canadian Academy of Pathology, the Renal Pathology Society, the American and the International Society of Nephrology.

Education and Stats

Our fellowship-trained pathologists have decades of experience interpreting biopsies.

Download CV
Joined the Arkana Team 2009
Doctor of Medicine University of Arkansas for Medical Sciences
Anatomic Pathology Residency Emory University
Renal Pathology Fellowship Arkana Laboratories
Board Certification American Board of Pathology

Featured Publications from Chris Larsen, MD

Nephronophthisis: a pathological and genetic perspective Nephronophthisis: a pathological and genetic…

By Wolf MTF, Bonsib SM, Larsen CP, Hildebrandt F

November 2023

Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease and is one of the most frequent genetic causes…

Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease and is one of the most frequent genetic causes for kidney failure (KF) in children and adolescents. Over 20 genes cause NPHP and over 90 genes contribute to renal ciliopathies…

Read on Springer Link

Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year… Belatacept with time-limited tacrolimus…

By Johnson AC, Zhang J, Karadkhele G, Gragert L, Hertzberg V, Larsen CP

September 2023

Solid organ transplant donor-recipient eplet mismatch has been correlated with donor-specific antibody (DSA) formation,…

Solid organ transplant donor-recipient eplet mismatch has been correlated with donor-specific antibody (DSA) formation, antibody-mediated rejection, and overall rejection rates. However, studies have been predominantly in patients on…

Read on amjtransplant.org

Clinical and Histopathologic Characteristics of Pediatric Patients With Primary… Clinical and Histopathologic Characteristics of…

By Kouri AM, Caza TN, Beck LH Jr., Misurac JM, Evans MD, Phillips CL, Eadon MT, Larsen CP, Andreoli SP, Bu L, Rheault MN, Khalid M

August 2023

Primary membranous nephropathy (PMN) is uncommon in children. Therefore, data on the clinical course of affected…

Primary membranous nephropathy (PMN) is uncommon in children. Therefore, data on the clinical course of affected children are scarce. In recent years, several novel antigens have been implicated in the pathogenesis of PMN. However, the…

Read on kirereports.org

The Characteristics of Concurrent Anti-Glomerular Basement Membrane Nephritis and… The Characteristics of Concurrent Anti-Glomerular…

By Bu L, Said SM, Herrera Hernandez L, Taheri Z, Spry L, Rosenthal BS, Das A, Madden B, Larsen CP, Kim Y, Sethi S, Nasr SH

August 2023

Concurrent anti-glomerular basementmembrane (GBM) nephritis and membranous nephropathy (MN) is rare and previously…

Concurrent anti-glomerular basementmembrane (GBM) nephritis and membranous nephropathy (MN) is rare and previously addressed only in case reports or small series (≤12 patients). The target antigen(s) in MN associated with anti-GBM nephritis are…

Read on kirereports.org

Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy Clinicopathologic Spectrum of Lysozyme-Associated…

By Kudose S, Cossey LN, Canetta PA, Sekulic M, Vanbeek CA, Huls FB, Gupta I, Bu L, Alexander MP, Cornell LD, Fidler ME, Markowitz GS, Larsen CP, D'Agati VD, Nasr SH,…

May 2023

Lysozyme-associated nephropathy (LyN), a rare cause of kidney injury in patients with chronic myelomonocytic leukemia…

Lysozyme-associated nephropathy (LyN), a rare cause of kidney injury in patients with chronic myelomonocytic leukemia (CMML), has not been well described to date. We report the clinicopathologic spectrum of LyN from a multi-institutional series.

Read on kirereports.org

Doctor Directory

Josephine Ambruzs, MD, MPH

Nephropathologist

Alejandro Best, MD

Nephropathologist, Fellowship Director

Vanesa Bijol, MD

Nephropathologist

Christie Boils, MD

Nephropathologist

Stephen Bonsib, MD, MS

Emeritus Nephropathologist

T. David Bourne, MD

Neuropathologist, Nephropathologist

Clarissa Cassol, MD

Nephropathologist

Tiffany Caza, MD, PhD

Nephropathologist, Scientist

River Charles, MD

Nephropathologist

Shana Coley, MD, PhD

Nephropathologist

L. Nicholas Cossey, MD

Physician Director, Nephropathologist

Rachelle Gietzen, MD

Nephropathologist

Samar Hassen, PhD

Research Scientist

Randy Haun, PhD

Senior Scientist

Danni Holanda, MD

Nephropathologist

Daniel Kenan, MD, PhD

Nephropathologist, Director of Innovation

Chris Larsen, MD

Executive Director, Nephropathologist

Rebecca May, MD, PhD

Nephropathologist

Paul Miller, MD

Nephropathologist, Associate Fellowship Program Director

Odia Molen, MD

Nephropathologist

Joel Murphy, MD

Nephropathologist, Visiting Scholars Program Director

Mohammad Obeidat, MD

Nephropathologist

Jason Paris, PhD

Director of Contract Research

Miran Rhee-Anagnost, MD

Nephropathologist

Shree Sharma, MD

Laboratory Director, Nephropathologist

Fred Silva, MD

Emeritus Nephropathologist

Jaime Singh, MD

Nephropathologist

Joshua Sonnen, MD

Neuropathologist

Cherry Starling, MD

Nephropathologist

Aaron Storey, PhD

Director of Mass Spectrometry Laboratory

Patrick D. Walker, MD

Founder, Nephropathologist

Jon Wilson, MD

Neuropathologist, Molecular Pathologist

Jason Paris, PhD

Director of Contract Research

Josephine Ambruzs, MD, MPH

Nephropathologist

Alejandro Best, MD

Nephropathologist, Fellowship Director

Vanesa Bijol, MD

Nephropathologist

Christie Boils, MD

Nephropathologist

Stephen Bonsib, MD, MS

Emeritus Nephropathologist

T. David Bourne, MD

Neuropathologist, Nephropathologist

Clarissa Cassol, MD

Nephropathologist

Tiffany Caza, MD, PhD

Nephropathologist, Scientist

River Charles, MD

Nephropathologist

Shana Coley, MD, PhD

Nephropathologist

L. Nicholas Cossey, MD

Physician Director, Nephropathologist

Rachelle Gietzen, MD

Nephropathologist

Danni Holanda, MD

Nephropathologist

Daniel Kenan, MD, PhD

Nephropathologist, Director of Innovation

Chris Larsen, MD

Executive Director, Nephropathologist

Rebecca May, MD, PhD

Nephropathologist

Paul Miller, MD

Nephropathologist, Associate Fellowship Program Director

Odia Molen, MD

Nephropathologist

Joel Murphy, MD

Nephropathologist, Visiting Scholars Program Director

Mohammad Obeidat, MD

Nephropathologist

Miran Rhee-Anagnost, MD

Nephropathologist

Shree Sharma, MD

Laboratory Director, Nephropathologist

Fred Silva, MD

Emeritus Nephropathologist

Jaime Singh, MD

Nephropathologist

Cherry Starling, MD

Nephropathologist

Patrick D. Walker, MD

Founder, Nephropathologist

T. David Bourne, MD

Neuropathologist, Nephropathologist

Joshua Sonnen, MD

Neuropathologist

Jon Wilson, MD

Neuropathologist, Molecular Pathologist

Shana Coley, MD, PhD

Nephropathologist

Samar Hassen, PhD

Research Scientist

Randy Haun, PhD

Senior Scientist

Daniel Kenan, MD, PhD

Nephropathologist, Director of Innovation

Aaron Storey, PhD

Director of Mass Spectrometry Laboratory

Meet All Doctors and Team